Literature DB >> 29624161

E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line.

Erin Isaacson Wechsler1, Sharof Tugizov1, Rossana Herrera1, Maria Da Costa1, Joel M Palefsky1.   

Abstract

We created the first human papillomavirus (HPV)-16-immortalized anal epithelial cell line, known as AKC2 cells to establish an in vitro model of HPV-16-induced anal carcinogenesis. Consistent with detection of E6, E7 and E5 expression in anal cancer biopsies, AKC2 cells expressed high levels of all three HPV oncogenes. Also, similar to findings in anal cancer biopsies, epidermal growth factor receptor (EGFR) was overexpressed in AKC2 cells. AKC2 cells exhibited a poorly differentiated and invasive phenotype in three-dimensional raft culture and inhibition of EGFR function abrogated AKC2 invasion. Reducing E5 expression using E5-targeted siRNAs in AKC2 cells led to knockdown of E5 expression, but also HPV-16 E2, E6 and E7 expression. AKC2 cells treated with E5-targeted siRNA had reduced levels of total and phosphorylated EGFR, and reduced invasion. Rescue of E6/E7 expression with simultaneous E5 knockdown confirmed that E5 plays a key role in EGFR overexpression and EGFR-induced invasion.

Entities:  

Keywords:  HPV 16 E5; HPV 16-postive anal cell line; Human Papillomaviruses; anal cancer; epidermal growth factor

Mesh:

Substances:

Year:  2018        PMID: 29624161      PMCID: PMC6537625          DOI: 10.1099/jgv.0.001061

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  53 in total

1.  Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation.

Authors:  Frauke Fehrmann; David J Klumpp; Laimonis A Laimins
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase.

Authors:  Z Lu; G Jiang; P Blume-Jensen; T Hunter
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

3.  Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes.

Authors:  G S Akerman; W H Tolleson; K L Brown; L L Zyzak; E Mourateva; T S Engin; A Basaraba; A L Coker; K E Creek; L Pirisi
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

4.  Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes.

Authors:  R Klaes; S M Woerner; R Ridder; N Wentzensen; M Duerst; A Schneider; B Lotz; P Melsheimer; M von Knebel Doeberitz
Journal:  Cancer Res       Date:  1999-12-15       Impact factor: 12.701

5.  Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.

Authors:  Feng Wang-Johanning; Danielle W Lu; Yueying Wang; Martin R Johnson; Gary L Johanning
Journal:  Cancer       Date:  2002-04-15       Impact factor: 6.860

6.  Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle.

Authors:  Sybil M Genther; Stephanie Sterling; Stefan Duensing; Karl Münger; Carol Sattler; Paul F Lambert
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

7.  Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer.

Authors:  S P Mathur; R S Mathur; R C Young
Journal:  Am J Reprod Immunol       Date:  2000-10       Impact factor: 3.886

8.  The expression of HPV-16 E5 protein in squamous neoplastic changes in the uterine cervix.

Authors:  J L Chang; Y P Tsao; D W Liu; S J Huang; W H Lee; S L Chen
Journal:  J Biomed Sci       Date:  2001 Mar-Apr       Impact factor: 8.410

9.  The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus.

Authors:  P Leechanachai; L Banks; F Moreau; G Matlashewski
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

10.  Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers.

Authors:  Kate Middleton; Woei Peh; Shirley Southern; Heather Griffin; Karl Sotlar; Tomomi Nakahara; Amira El-Sherif; Lesley Morris; Rashmi Seth; Merilyn Hibma; David Jenkins; Paul Lambert; Nicholas Coleman; John Doorbar
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more
  6 in total

1.  The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses.

Authors:  Sarah Jill de Jong; Amandine Créquer; Irina Matos; David Hum; Vignesh Gunasekharan; Lazaro Lorenzo; Fabienne Jabot-Hanin; Elias Imahorn; Andres A Arias; Hassan Vahidnezhad; Leila Youssefian; Janet G Markle; Etienne Patin; Aurelia D'Amico; Claire Q F Wang; Florian Full; Armin Ensser; Tina M Leisner; Leslie V Parise; Matthieu Bouaziz; Nataly Portilla Maya; Xavier Rueda Cadena; Bayaki Saka; Amir Hossein Saeidian; Nessa Aghazadeh; Sirous Zeinali; Peter Itin; James G Krueger; Lou Laimins; Laurent Abel; Elaine Fuchs; Jouni Uitto; Jose Luis Franco; Bettina Burger; Gérard Orth; Emmanuelle Jouanguy; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2018-08-01       Impact factor: 17.579

Review 2.  Oncogenic Effects of HIV-1 Proteins, Mechanisms Behind.

Authors:  Maria Isaguliants; Ekaterina Bayurova; Darya Avdoshina; Alla Kondrashova; Francesca Chiodi; Joel M Palefsky
Journal:  Cancers (Basel)       Date:  2021-01-15       Impact factor: 6.639

3.  Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab.

Authors:  Lucía Trilla-Fuertes; Angelo Gámez-Pozo; Joan Maurel; Rocio Garcia-Carbonero; Jaume Capdevila; Laura G-Pastrián; Marta Mendiola; Cristina Peña; Rocío López-Vacas; Miriam Cuatrecasas; Pilar García-Alfonso; Ricardo Ramos-Ruiz; Carlos Llorens; Ismael Ghanem; Carles Conill; Victoria Heredia-Soto; Ángel Campos-Barros; Juan Ángel Fresno Vara; Jaime Feliu
Journal:  Sci Rep       Date:  2021-04-01       Impact factor: 4.379

4.  Molecular and genomic characterisation of a panel of human anal cancer cell lines.

Authors:  Alexander G Heriot; Robert G Ramsay; Wayne A Phillips; Glen R Guerra; Joseph C Kong; Rosemary M Millen; Matthew Read; David S Liu; Sara Roth; Shienny Sampurno; Joseph Sia; Maria-Pia Bernardi; Timothy J Chittleborough; Corina C Behrenbruch; Jiasian Teh; Huiling Xu; Nicole M Haynes; Jiaan Yu; Richard Lupat; David Hawkes; Natasha Di Costanzo; Richard W Tothill; Catherine Mitchell; Samuel Y Ngan
Journal:  Cell Death Dis       Date:  2021-10-18       Impact factor: 8.469

Review 5.  In Vitro Organotypic Systems to Model Tumor Microenvironment in Human Papillomavirus (HPV)-Related Cancers.

Authors:  Vincenza De Gregorio; Francesco Urciuolo; Paolo Antonio Netti; Giorgia Imparato
Journal:  Cancers (Basel)       Date:  2020-05-03       Impact factor: 6.639

6.  A Novel Model for Papillomavirus-Mediated Anal Disease and Cancer Using the Mouse Papillomavirus.

Authors:  Simon Blaine-Sauer; Myeong-Kyun Shin; Kristina A Matkowskyj; Ella Ward-Shaw; Paul F Lambert
Journal:  mBio       Date:  2021-07-20       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.